Cannabis Stocks Rally on Trump Executive Order Rumors: Tim Seymour Explains

Potential Rescheduling of Cannabis

• 💡 Rescheduling cannabis from Schedule I to Schedule III is a key hope for investors, with any hint of it causing stocks to surge.
• 🚀 This move is seen as real this time, potentially driven by an administrative order rather than legislation, making it a priority for President Trump.
• 🧠 The cannabis industry has actively engaged Washington, with CEOs meeting with the president's team and influential figures weighing in on the benefits of rescheduling.

Implications of Schedule III Reclassification

• 🎯 Schedule III would effectively legalize the medical cannabis market.
• 💸 It would also significantly alter the tax structure, as Schedule I taxation makes it nearly impossible for companies to be profitable on gross profits.
• 📈 This could provide a boom for free cash flow in the 2025 calendar year, especially if enacted before the end of the tax year.

Broader Industry Impact

• 🔑 A major implication is the potential for exchange listings, which could attract much-needed institutional capital to the cannabis sector.
• 🧩 Beyond listings, rescheduling could act as a domino effect, triggering other positive developments for the industry without requiring legislative action.
• 📊 The industry has seen significant stock surges, with the Amplify Seymour Cannabis ETF experiencing its best day on record, up nearly 55%.
• ⚠️ Despite previous headlines, current dynamics and sources in Washington suggest this development feels different.